{{redirect|冰毒}}
{{redirect3|豬肉 (毒品)}}
{{medical}}
{{Multiple issues|
{{refimprove|time=2018-05-01T20:43:10+00:00}}
{{expand English|Methamphetamine|ga=yes}}
{{medref|time=2015-06-13T12:37:53+00:00}}
}}
{{NoteTA|G1=Chemistry|G2=Medicine}}
{{Infobox drug
| verifiedrevid = 589084691
| IUPAC_name = ''N''-甲基-1-苯基丙-2-胺
| image = Methamphetamine.svg
| alt = An image of the methamphetamine compound
| image2 = Levomethamphetamine molecule ball from xtal.png
| width2 = 250px
| alt2 = Ball-and-stick model of the methamphetamine molecule

<!--Clinical data-->
| tradename = Desoxyn
| Drugs.com = {{Drugs.com|monograph|methamphetamine-hydrochloride}}
| pregnancy_AU =
| pregnancy_US = C
| dependency_liability = ''生理'': 無<br />''心理'': 高
| addiction_liability = 高
| legal_AU = S8
| legal_CA = Schedule I
| legal_UK = {{tsl|en|Drugs controlled by the UK Misuse of Drugs Act#Class A drugs||Class A}}
| legal_US = Schedule II
| legal_CN = recreational
| legal_UN = [[精神药物公约|Schedule II]]
| licence_US = Desoxyn
| legal_status = Rx-only
| routes_of_administration= ''Medical'': oral<br>''Recreational'': oral, intravenous, insufflation, inhalation, suppository

<!--Pharmacokinetic data-->
| bioavailability= Oral: Varies widely<ref name="Pubchem1" /><br/>Rectal: 99%<br/>IV: 100%
| protein_bound = Varies widely<ref name="Pubchem1">{{cite encyclopedia | title=Methamphetamine | section-url=https://pubchem.ncbi.nlm.nih.gov/compound/1206#section=Toxicity | work=PubChem Compound | publisher=National Center for Biotechnology Information | accessdate=31 December 2013 | section=Toxicity | archive-date=2015-01-04 | archive-url=https://web.archive.org/web/20150104182703/https://pubchem.ncbi.nlm.nih.gov/compound/1206#section=Toxicity | dead-url=no }}</ref>
| metabolism =[[CYP2D6|CYP2D6]],<ref name="FDA Pharmacokinetics">{{cite web | title = Adderall XR Prescribing Information | url = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf | pages = 12–13 | work = United States Food and Drug Administration | date = December 2013 | accessdate = 30 December 2013 | archive-date = 2018-07-18 | archive-url = https://web.archive.org/web/20180718220437/https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf | dead-url = no }}</ref> [[多巴胺β羟化酶|DBH]]<ref name="DBH ref">{{cite book | title=Foye's Principles of Medicinal Chemistry | year=2013 | publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins | location=Philadelphia | isbn=1609133455 | page=648 | author=Lemke TL, Williams DA, Roche VF, Zito W|edition=7th ed. | quote=Alternatively, direct oxidation of amphetamine by DA β-hydroxylase can afford norephedrine.}}</ref>、{{tsl|en|Flavin-containing monooxygenase||FMO3}},<ref name="FMO">{{cite journal | author = Krueger SK, Williams DE | title = Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism | journal = Pharmacol. Ther. | volume = 106 | issue = 3 | pages = 357–387 |date=June 2005 | pmid = 15922018 | pmc = 1828602 | doi = 10.1016/j.pharmthera.2005.01.001 }}</ref> {{tsl|en|butyrate-CoA ligase||XM-ligase}},<ref name="Benzoic1">{{cite encyclopedia| title=butyrate-CoA ligase| section-url=http://www.brenda-enzymes.info/enzyme.php?ecno=6.2.1.2&Suchword=&organism%5B%5D=Homo+sapiens&show_tm=0| work=BRENDA| publisher=Technische Universität Braunschweig.| accessdate=7 May 2014| section=Substrate/Product| archive-date=2017-06-22| archive-url=https://web.archive.org/web/20170622234353/http://www.brenda-enzymes.info/enzyme.php?ecno=6.2.1.2&Suchword=&organism%5B%5D=Homo+sapiens&show_tm=0| dead-url=no}}</ref> and {{tsl|en|glycine N-acyltransferase||ACGNAT}}<ref name="Benzoic2">{{cite encyclopedia| title=glycine N-acyltransferase| section-url=http://www.brenda-enzymes.info/enzyme.php?ecno=2.3.1.13&Suchword=&organism%5B%5D=Homo+sapiens&show_tm=0| work=BRENDA| publisher=Technische Universität Braunschweig.| accessdate=7 May 2014| section=Substrate/Product| archive-date=2017-06-23| archive-url=https://web.archive.org/web/20170623000309/http://www.brenda-enzymes.info/enzyme.php?ecno=2.3.1.13&Suchword=&organism%5B%5D=Homo+sapiens&show_tm=0| dead-url=no}}</ref>
| elimination_half-life= 9–12 hours<ref name="Schep">{{cite journal |vauthors=Schep LJ, Slaughter RJ, Beasley DM |title=The clinical toxicology of metamfetamine |journal=Clinical Toxicology |volume=48 |issue=7 |pages=675–694 |date=August 2010 |pmid=20849327 |doi=10.3109/15563650.2010.516752|issn=1556-3650}}</ref>
| excretion = [[腎|腎]]

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number=537-46-2
| ATC_prefix=N06
| ATC_suffix=BA03
| ATC_supplemental=
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 6809
| IUPHAR_ligand = 4803
| PDB_ligand =
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MYWUZJCMWCOHBA-UHFFFAOYSA-N
| PubChem=1206
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank=DB01577
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1169
| NIAID_ChemDB =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 44RAL3456C
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08187
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1201201

<!--Chemical data-->
| C=10 | H=15 | N=1
| molecular_weight = 149.2337 g/mol
| smiles = N(C(Cc1ccccc1)C)C
| InChI = 1/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3
| InChIKey = MYWUZJCMWCOHBA-UHFFFAOYAT
| synonyms = ''N''-methylamphetamine, desoxyephedrine
| boiling_point = 212
| boiling_notes = <ref name="Pubchem2">{{cite encyclopedia | title=Methamphetamine | section-url=https://pubchem.ncbi.nlm.nih.gov/compound/1206#section=Chemical-and-Physical-Properties | work=PubChem Compound | publisher=National Center for Biotechnology Information | accessdate=31 December 2013 | section=Chemical and Physical Properties | archive-date=2015-01-04 | archive-url=https://web.archive.org/web/20150104182703/https://pubchem.ncbi.nlm.nih.gov/compound/1206#section=Chemical-and-Physical-Properties | dead-url=no }}</ref> at {{nowrap|760 mmHg}}
| melting_point = 3
| melting_notes = <ref name="Chemspider">{{cite encyclopedia | section-url=http://www.chemspider.com/Chemical-Structure.1169 | work=Chemspider | title=Methmphetamine | accessdate=3 January 2013 | section=Properties: Predicted – EP{{pipe}}Suite | archive-date=2014-01-03 | archive-url=https://web.archive.org/web/20140103230627/http://www.chemspider.com/Chemical-Structure.1169 | dead-url=no }}</ref>
}}
[[File:Methamphetamine-3d-CPK.png|thumb]]

'''甲基苯丙胺'''或'''甲基安非他命'''（英語：'''methamphetamine'''，全名{{nowrap|'''''N''-{{tsl|en|methylamphetamine}}'''}}{{#tag:ref|Synonyms and alternate spellings include: metamfetamine ([[国际非专利药品名称|International Nonproprietary Name (INN)]]), ''N''-methylamphetamine, desoxyephedrine, Syndrox, Methedrine, and Desoxyn.<ref name="EMCDDA profile">{{cite web |url=http://www.emcdda.europa.eu/publications/drug-profiles/methamphetamine |title=Methamphetamine |date=16 August 2010 |work=Drug profiles |publisher={{tsl|en|European Monitoring Centre for Drugs and Drug Addiction||European Monitoring Centre for Drugs and Drug Addiction}} (EMCDDA) |accessdate=1 September 2011 |archive-date=2016-04-15 |archive-url=https://web.archive.org/web/20160415220149/http://www.emcdda.europa.eu/publications/drug-profiles/methamphetamine |dead-url=no }}</ref><ref name="DB ID">{{cite encyclopedia | title=Methamphetamine | section-url=http://www.drugbank.ca/drugs/DB01577#identification | work=DrugBank | publisher=University of Alberta | accessdate=31 December 2013 | date=8 February 2013 | section=Identification | archive-date=2015-12-28 | archive-url=https://web.archive.org/web/20151228164940/http://www.drugbank.ca/drugs/DB01577#identification | dead-url=no }}</ref><ref>{{cite web |url=http://addictionlibrary.org/prescription/methedrine.html |title=Methedrine (methamphetamine hydrochloride): Uses, Symptoms, Signs and Addiction Treatment |newspaper=Addictionlibrary.org |date= |accessdate=16 January 2016 |archive-date=2016-03-04 |archive-url=https://web.archive.org/web/20160304045442/http://addictionlibrary.org/prescription/methedrine.html |dead-url=no }}</ref> Common slang terms for methamphetamine include: speed, meth, crystal, crystal meth, glass, shards, ice, and tic<ref>{{cite web|title=Meth Slang Names|url=http://www.methhelponline.com/meth-slang.htm|work=MethhelpOnline|accessdate=1 January 2014|archive-date=2013-12-07|archive-url=https://web.archive.org/web/20131207185806/http://www.methhelponline.com/meth-slang.htm|dead-url=no}}</ref> and, in New Zealand, "P".<ref>{{cite web|url=http://www.police.govt.nz/advice/drugs-and-alcohol/methamphetamine-and-law|title=Methamphetamine and the law|publisher=|accessdate=2018-05-02|archive-date=2015-01-28|archive-url=https://web.archive.org/web/20150128175632/http://www.police.govt.nz/advice/drugs-and-alcohol/methamphetamine-and-law|dead-url=no}}</ref>| group = "note" }}），[[结构简式|化学式]]：C₆H₅CH₂CH(CH₃)NHCH₃（'''''N''-甲基-1-苯基丙-2-胺'''、'''''N''-甲基-α-甲基苯乙胺'''），其[[结晶|结晶]]形态俗稱'''冰毒'''、黑话「'''豬肉'''」，是一种強效[[中樞神經系統|中樞神經系統]][[興奮劑|興奮劑]]，主要被用於[[娛樂性藥物|毒品]]，較少被用於治療[[注意力不足過動症|注意力不足過動症]]和[[肥胖症|肥胖症]]，即便有也被當成[[疗法|第二線療法]]<ref name="Recent advances in methamphetamine neurotoxicity - 2015 review">{{cite journal | vauthors = Yu S, Zhu L, Shen Q, Bai X, Di X | title = Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology | journal = Behav. Neurol. | volume = 2015 | issue = | pages = 103969 | date = March 2015 | pmid = 25861156 | pmc = 4377385 | doi = 10.1155/2015/103969 | quote = In 1971, METH was restricted by US law, although oral METH (Ovation Pharmaceuticals) continues to be used today in the USA as a second-line treatment for a number of medical conditions, including attention deficit hyperactivity disorder (ADHD) and refractory obesity [3].}}</ref>。甲基苯丙胺是在1893年發現，有二種[[对映异构|对映异构]]：分別是[[左旋甲基苯丙胺|左旋甲基苯丙胺]]（levo-methamphetamine）及右旋甲基苯丙胺（dextro-methamphetamine）。「甲基苯丙胺」一般是指左旋甲基苯丙胺及右旋甲基苯丙胺各佔一半的[[外消旋混合物|外消旋混合物]]。甲基安非他命較少被醫師處方，因為可能會{{tsl|en|neurotoxicity|神經中毒|毒害神經}}，以及有用作[[春藥|春藥]]和[[欣快感|欣快感]]促進劑等風險。而且已有療效相同，而對人體危害風險更低的[[替代品|替代藥物]]。

甲基苯丙胺可用在非醫療用途上，會被非法交易販售。甲基苯丙胺的非法使用在亚洲部分地区、大洋洲和美国最为普遍。在美国，消旋甲基苯丙胺、左旋及右旋甲基苯丙胺均为{{tsl|en|list of Schedule II drugs (US)|schedule II|第二类管制药品}}。左旋甲基苯丙胺的吸入型{{tsl|en|nasal decongestant||鼻塞緩解劑}}是美國的[[非处方药|非处方药]]，因此能直接在市面上購買{{#tag:ref|有些美國非處方藥的活化成份會列levmetamfetamine，是levomethamphetamine的[[国际非专利药品名称|INN]]及{{tsl|en|United States Adopted Name|美國藥物通用名|USAN}}<ref name="FDA levmetamfetamine">{{cite encyclopedia | title=Code of Federal Regulations Title 21: Subchapter D – Drugs for human use | section=Part 341 – cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use | section-url=https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=341.80 | website=United States Food and Drug Administration | accessdate=7 March 2016 | date=April 2015 | quote=Topical nasal decongestants --(i) For products containing levmetamfetamine identified in 341.20(b)(1) when used in an inhalant dosage form. The product delivers in each 800 milliliters of air 0.04 to 0.150 milligrams of levmetamfetamine. | archive-date=2015-09-18 | archive-url=https://web.archive.org/web/20150918190451/http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=341.80 | dead-url=no }}</ref><ref>{{cite encyclopedia| title=Levomethamphetamine| section=Identification| section-url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=36604#section=Identification| work=Pubchem Compound| publisher=National Center for Biotechnology Information| accessdate=2 January 2014| archive-date=2014-10-06| archive-url=https://web.archive.org/web/20141006215922/http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=36604#section=Identification| dead-url=no}}</ref>|name="OTC levmetamfetamine"|group = "note"}}。在國際上，甲基安非他命名列《[[精神药物公约|精神药物公约]]》中的第二級分類表（schedule II），因此在從事甲基安非他命的生產、散播、銷售和加工等活動都被許多國家嚴格管制或禁止。[[右旋安非他命|右旋安非他命]]（Dextromethamphetamine）的藥效比甲基苯丙胺更加強烈物，但因為甲基苯丙胺的[[化学合成|化学合成]]難度較低，其[[前体|前体]]較容易取得，因此比較容易非法製造生產甲基苯丙胺。

低劑量服用甲基安非他命，會產生[[欣快感|欣快感]]、提振警醒度、專注力和精神及降低食慾、減輕體重。高劑量服用甲基安非他命則會引起{{tsl|en|stimulant psychosis||中樞神經刺激劑引起的精神病}}、[[横纹肌溶解症|横纹肌溶解症]]、{{tsl|en|Generalized seizures||全身癲癇}}和[[顱內出血|顱內出血]]。
長期攝取高劑量的甲基安非他命可能加快那些不可預期且速度極快的副作用，例如：{{tsl|en|mood swing||心情擺盪}}、{{tsl|en|stimulant psychosis||中樞神經刺激劑引起的精神病}}（譬如：[[偏執狂|偏執]]、[[幻觉|幻觉]]、[[譫妄|譫妄]]和[[妄想|妄想]]等），及[[侵略_(社會科學)|具有侵略性的行為]]。
在娛樂用途上，甲基安非他命{{tsl|en|wakefulness-promoting agent|increase energy|提升能量}}的效果主要體現於[[欣快|提振心情]]和[[春药|增加性慾]]，讓使用的人能連續從事性行為好幾天<ref name="SF Meth">{{cite AV media |date=August 2013 |title=San Francisco Meth Zombies |medium=TV documentary |url=http://channel.nationalgeographic.com/drugs-inc/episodes/san-francisco-meth-zombies/ |publisher=National Geographic Channel |asin=B00EHAOBAO |access-date=2018-06-22 |archive-date=2016-07-08 |archive-url=https://web.archive.org/web/20160708142916/http://channel.nationalgeographic.com/drugs-inc/episodes/san-francisco-meth-zombies/ |dead-url=no }}</ref>。
已知甲基安非他命能產生高度的[[成瘾|成瘾]]依賴（亦即：長期使用或超高劑量使用有相當高的可能性導致使用者出現衝動用藥。）和高度[[物質依賴|物質依賴]]（亦即：在戒除甲基安非他命時有高度的可能性會有戒斷症狀發生）
甲基苯丙胺的高劑量非醫療使用可能會造成[[急性戒断综合征|急性戒断综合征]]，其持續時間可能會比一般的戒断時間更長。甲基苯丙胺和[[苯丙胺|苯丙胺]]不同，甲基苯丙胺有{{link-en|神經毒性|neurotoxicity}}，會影響人類{{link-en|多巴胺能通道|Dopaminergic pathways|多巴胺能}}的[[神經元|神經元]]<ref name="Malenka" />，也已證實甲基苯丙胺會傷害中樞神經系統中的[[血清素|血清素]]神經元<ref name="Low dose Ntox">{{cite journal |vauthors = Yu S, Zhu L, Shen Q, Bai X, Di X |title = Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology |journal = Behav Neurol |volume = 2015 |issue = |pages = 1–11 |year = 2015 |pmid = 25861156 |pmc = 4377385 |doi = 10.1155/2015/103969 |url = }}</ref><ref name="pmid19328213" />，這些傷害包括腦部結構及功能的不良變化，例如不同腦部區域中[[灰质|灰质]]體積的減少，以及代謝整合性標誌物的不良變化<ref name="pmid19328213" />。

甲基苯丙胺在{{link-en|化合物分類|Chemical classification}}上屬於[[苯乙胺衍生物|苯乙胺衍生物]]及{{link-en|苯丙胺衍生物|substituted amphetamine}}，和其他的{{link-en|二甲基苯乙胺|dimethylphenethylamine}}互為[[结构异构|结构异构]]，有共同的[[化学式|化学式]]：{{chemical formula|C|10|H|15|N}} 。
{{TOC limit|3}}

== 用途 ==
=== 医用 ===
d-甲基安非他命，药品商标Desoxyn®，医疗上用于治疗[[注意力不足過動症|注意力不足過動症]]（ADHD）、嗜睡症以及极端的[[肥胖症|肥胖症]]等。它的[[右旋|右旋]]异构体（R+[[异构体|异构体]]）可以用于治疗[[注意力不足過動症|注意力不足過動症]]，但不带甲基的[[安非他命|安非他命]]更常用。它的右旋异构体药品商标为「Desoxyn」，可以用于治疗[[嗜睡症|嗜睡症]]及[[肥胖|肥胖]]。当安非他命和甲基安非他命致使患者太多副作用时，Desoxyn作为次选药物。在精神方面的作用上，右旋的R(+)构型是左旋的S(-)构型的5倍<ref>张建新，张大明，等。从甲基苯丙胺的对映体特征推断前体化学品。卫生研究，2009，04. http://www.cnki.com.cn/Article/CJFDTotal-WSYJ200904015.htm {{Wayback|url=http://www.cnki.com.cn/Article/CJFDTotal-WSYJ200904015.htm |date=20151118102016 }}</ref>。

===精神性毒品===
因其具有强效的欣快作用和催情作用<ref name="SF Meth" />，通常被用于娱乐，根据[[國家地理頻道|国家地理电视台]]关于甲基苯丙胺的纪录片，有些派对亚文化中以性和甲基苯丙胺作为基础<ref name="SF Meth" /> <ref name="SF Meth" /> ，由于其强烈的兴奋性和催情作用（对射精具有抑制作用），重复使用后可能连续几天都会发生性关系<ref name="SF Meth" /> 。甲基苯丙胺对精神的影响是强烈的，一段时间后会明显伴有睡眠过度的状况（白天过度嗜睡）。这些派对和游戏的亚文化流行于[[旧金山|旧金山]]和[[纽约|纽约]]两大城市<ref name="SF Meth" /> <ref>{{cite book |last1 = Nelson |first1 = Lewis S. |last2 = Lewin |first2 = Neal A. |last3 = Howland |first3 = Mary Ann |last4 = Hoffman |first4 = Robert S. |last5 = Goldfrank |first5 = Lewis R. |last6 = Flomenbaum |first6 = Neal E. |name-list-format = vanc |title = Goldfrank's toxicologic emergencies |date = 2011 |publisher = McGraw-Hill Medical |location = New York |isbn = 978-0-07-160593-9 |edition = 9th |page = 1080 }}</ref>。
{{multiple image
<!-- Essential parameters -->
| align     = center
| direction = horizontal
| width     =
<!-- Extra parameters -->
| header =
| header_align = center
| header_background =
| footer =
| footer_align =
| footer_background =
| background color =
<!-- Images – the template can take up to 10 -->
|image1=Desoxyn (methamphetamine) 5 mg tablets.jpg
|image2=Blue Crystal Meth.jpg
<!-- Image parameters – width is ignored if the "essential parameter" width is specified -->
|width1=260
|caption1=Desoxyn® 药片 药用甲基苯丙胺
|alt1=Desoxyn® 药片
|width2=236
|caption2=冰毒晶体 非法甲基苯丙胺
|alt2=冰毒晶体
}}
{{clear}}
== 禁忌症 ==
有以下症状的人不能使用甲基苯丙胺：曾有[[物質使用疾患|物質使用疾患]]、[[心血管疾病|心血管疾病]]或嚴重[[应激性|易怒]]或焦慮的人，若仍有[[动脉血管硬化|动脉血管硬化]]、[[青光眼|青光眼]]、[[甲状腺功能亢进症|甲状腺功能亢进症]]或嚴重[[高血壓|高血壓]]，也不能使用甲基苯丙胺<ref name="Desoxyn">{{cite web| title=Desoxyn Prescribing Information| url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/005378s028lbl.pdf| date=December 2013| work=United States Food and Drug Administration| accessdate=6 January 2014| archive-date=2014-01-02| archive-url=https://web.archive.org/web/20140102192621/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/005378s028lbl.pdf| dead-url=no}}</ref>。

美国食品药品监督管理局（FDA）表示，若以往曾對其他的興奮劑有[[超敏反應|超敏反應]]，或是正在使用[[单胺氧化酶抑制剂|单胺氧化酶抑制剂]]，也不得使用甲基苯丙胺<ref name="Desoxyn" />。FDA也建議有[[躁鬱症|躁鬱症]]、[[重性抑郁障碍|重性抑郁障碍]]、[[血壓|血壓]]偏高、有肝腎臟疾病、[[狂躁|狂躁]]、[[思覺失調|思覺失調]]、[[雷诺氏综合征|雷诺氏综合征]]、[[癲癇發作|癲癇發作]]、[[甲状腺|甲状腺]]問題、[[抽动综合症|抽动综合症]]或是[[妥瑞症|妥瑞症]]的病患，若要使用甲基苯丙胺需監控其症狀<ref name="Desoxyn" />。因為甲基苯丙胺有可能造成生長發育遲緩，FDA也建議若用甲基苯丙胺對兒童或青少年進行治療，需監控其身高及體重的資訊<ref name="Desoxyn" />。

== 副作用 ==

=== 生理 ===
甲基苯丙胺在生理上造成的副作用包括：[[食欲不振|食欲不振]]、過動、[[瞳孔放大|瞳孔放大]]（[[散瞳|散瞳]]）、[[汗液|過度流汗]]、{{link-en|精神運動性激動|Psychomotor agitation}}、口乾及[[磨牙|磨牙]]（會造成{{link-en|甲基苯丙胺嘴|meth mouth}}）、頭痛、[[心律不整|心律不整]]（可能是[[心跳过速|心跳过速]]或[[心跳过缓|心跳过缓]]）、[[呼吸急促|呼吸急促]]、[[高血壓|高血壓]]或[[低血壓|低血壓]]、[[高熱|體溫過高]]、腹瀉或便秘、{{link-en|視線模糊|blurred vision}}、[[頭暈|頭暈]]、{{link-en|肌束震顫|Fasciculation}}、[[麻木|麻木]]、[[顫抖|顫抖]]、皮膚乾燥、[[痤疮|痤疮]]及{{link-en|皮膚蒼白|pallor}}或{{link-en|皮膚發紅|Flushing (physiology)}}<ref>{{cite web|title=Methamphetamine Side Effects|url=https://www.drugs.com/sfx/methamphetamine-side-effects.html|website=Drugs.com|accessdate=28 November 2017|archive-date=2018-07-13|archive-url=https://web.archive.org/web/20180713014542/https://www.drugs.com/sfx/methamphetamine-side-effects.html|dead-url=no}}</ref>。慢性高劑量使用的副作用有{{link-en|搔癢障礙|excoriation disorder}}、身體異常的搔癢<!--and skin picking--><ref>https://addictionresource.com/drugs/crystal-meth/meth-sores/</ref>。{{ums|certain=y|date=November 2017}}及{{link-en|蟻走感|formication}}（感覺有昆蟲在身上爬的感覺）<ref name="NeurClin">{{cite journal|last1=Rusinyak|first1=Daniel E.|title=Neurologic manifestations of chronic methamphetamine abuse|journal=Neurologic Clinics|date=2011|volume=29|issue=3|pages=641–655|doi=10.1016/j.ncl.2011.05.004|pmc=3148451|pmid=21803215}}</ref>。可能會有{{le|腳抽筋|charley horse}}之類的症狀，有時會格外嚴重，且時間會拉長，若長期使用下，因為飲食不當以及[[脱水|脱水]]造成的[[電解質不平衡|電解質不平衡]]，此症狀會格外危險<ref name="Westfall">{{cite book | veditors = Brunton LL, Chabner BA, Knollmann BC | title = Goodman & Gilman's Pharmacological Basis of Therapeutics | year = 2010 | publisher = McGraw-Hill | location = New York | isbn = 978-0-07-162442-8 | vauthors = Westfall DP, Westfall TC | section = Miscellaneous Sympathomimetic Agonists | sectionurl = http://www.accessmedicine.com/content.aspx?aID=16661601 | edition = 12th | access-date = 2018-05-11 | archive-date = 2013-11-10 | archive-url = https://web.archive.org/web/20131110094145/http://www.accessmedicine.com/content.aspx?aID=16661601 | dead-url = no }}</ref>。
===冰毒嘴===
[[File:Suspectedmethmouth09-19-05.jpg|thumb]]
甲基苯丙胺使用者和成瘾者牙齿会快速脱落<ref name="pmid22782046" />，不管吸食毒品的方式如何都会造成此非正式命名的口腔疾病。注射者的状况最严重，而非那些吸入性的吸食方式<ref name="pmid22782046">{{cite journal |vauthors = Hussain F, Frare RW, Py Berrios KL |title = Drug abuse identification and pain management in dental patients: a case study and literature review |journal = Gen. Dent. |volume = 60 |issue = 4 |pages = 334–345 |year = 2012 |pmid = 22782046  }}</ref> ，根据{{link-en|美国牙科协会的说法|American Dental Association}}，冰毒嘴“可能是由所导致口干症（口干），以及药物引起的心理和生理上的变化，长时间较差的口腔卫生，经常摄入高热量食物、碳酸饮料和磨牙症联合作用所致<ref name="pmid22782046" /><ref name="ADA">{{cite web |url = http://www.ada.org/prof/resources/topics/methmouth.asp |title = Methamphetamine Use (Meth Mouth) |accessdate = 15 December 2006 |publisher = American Dental Association |archiveurl = https://web.archive.org/web/20080601035323/http://www.ada.org/prof/resources/topics/methmouth.asp |archivedate = June 2008 }}</ref>，由于口干也是其他兴奋剂的常见副作用，而这些药物并不会直接导致严重的龋齿，许多研究人员认为甲基苯丙胺相关的龋齿更多是由于吸食者的其他因素导致，他们认为副作用被夸大和风格化，以创造冰毒吸食者的刻板印象，以此作为对新吸食者的威慑。<ref name="pmid22089317">{{cite journal |vauthors = Hart CL, Marvin CB, Silver R, Smith EE |title = Is cognitive functioning impaired in methamphetamine users? A critical review |journal = Neuropsychopharmacology |volume = 37 |issue = 3 |pages = 586–608 |date = February 2012 |pmid = 22089317 |pmc = 3260986 |doi = 10.1038/npp.2011.276 |url = }}</ref>
===性病的传播===
甲基苯丙胺的使用被发现与[[艾滋病|艾滋病]]阳性和未知性伴侣中无保护性交频率更高有关，这种关联在艾滋病阳性参与者中更为明显，<ref name="STD" />这些研究结果表明，甲基苯丙胺在未受保护的肛交中的使用和参与是共同发生的危险行为，这些行为可能会增加[[男同性恋|男同性恋]]和[[双性恋|双性恋]]男性[[艾滋病病毒|艾滋病病毒]]传播的风险。<ref name="STD">{{cite journal |vauthors = Halkitis PN, Pandey Mukherjee P, Palamar JJ |title = Longitudinal Modeling of Methamphetamine Use and Sexual Risk Behaviors in Gay and Bisexual Men |journal = AIDS and Behavior |volume = 13 |issue = 4 |pages = 783–791 |year = 2008 |pmid = 18661225 |doi = 10.1007/s10461-008-9432-y |pmc = 4669892 }}</ref>使用甲基苯丙胺使男女使用者都能进行长时间的性活动，这可能导致男性生殖器疼痛和擦伤以及阴茎勃起功能障碍<ref name="Patrick Moore">{{cite web |author = Patrick Moore |url = http://www.villagevoice.com/2005-06-14/people/we-are-not-ok/ |title = We Are Not OK |publisher = VillageVoice |date = June 2005 |accessdate = 15 January 2011 |archive-date = 2011-06-04 |archive-url = https://web.archive.org/web/20110604154056/http://www.villagevoice.com/2005-06-14/people/we-are-not-ok/ |dead-url = no }}</ref>，甲基苯丙胺还可能通过磨牙症引起[[口腔溃疡|口腔溃疡]]和擦伤<ref name="Patrick Moore" />，增加了性传播感染的风险。除了性传播外通过注射器共用造成[[性病|性病]]的传播。<ref name="unsw">{{cite web |url = http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/NDLERF_Methamphetamine/$file/NDLERF+USE+AND+HEALTH.pdf |archiveurl = https://web.archive.org/web/20080816134234/http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/NDLERF_Methamphetamine/%24file/NDLERF%2BUSE%2BAND%2BHEALTH.pdf |archivedate = 16 August 2008 |format = PDF |title = Methamphetamine Use and Health | UNSW: The University of New South Wales – Faculty of Medicine |accessdate = 15 January 2011 |deadurl = yes |df = }}</ref>

==過量時的症狀==
甲基苯丙胺過量時會出現許多的症狀<ref name="Schep"/><ref name="Desoxyn" />。甲基苯丙胺中等程度的過量會有以下的症狀：[[心律不整|心律不整]]、意識不清、[[排尿疼痛|排尿疼痛]]、血壓偏高或是偏低、[[高熱|高熱]]、{{link-en|反射亢进|hyperreflexia|过度活跃和/或过度反应的反射}}、[[肌肉痛|肌肉痛]]、嚴重{{link-en|精神運動性激躁|Psychomotor agitation}}、[[呼吸急促|呼吸急促]]、[[顫抖|顫抖]]、排尿猶豫以及[[尿瀦留|無法排尿]]<ref name="Schep"/><ref name="Westfall" />。特別嚴重的過量會有[[肾上腺素风暴|肾上腺素风暴]]、{{link-en|甲基苯丙胺精神病|methamphetamine psychosis}}、[[无尿症|无尿症]]、, [[心源性休克|心源性休克]]、[[顱內出血|顱內出血]]、{{link-en|循環系統崩潰|circulatory collapse}}、危險性的[[发热|发热]]、[[肺高壓|肺高壓]]、[[腎功能衰竭|腎功能衰竭]]、[[横纹肌溶解症|横纹肌溶解症]]及[[血清素症候群|血清素症候群]]<!--and a form of {{link-en||stereotypy|stereotypy}} ("tweaking")-->{{#tag:ref|<ref name="Schep"/><ref name="Desoxyn" /><ref name="Westfall" /><ref name="Merck_Manual_Amphetamines">{{cite web |url = http://www.merckmanuals.com/professional/special_subjects/drug_use_and_dependence/amphetamines.html |author = O'Connor PG |title = Amphetamines |work = Merck Manual for Health Care Professionals |publisher = Merck |date = February 2012 |accessdate = 8 May 2012 |archive-date = 2012-05-06 |archive-url = https://web.archive.org/web/20120506232123/http://www.merckmanuals.com/professional/special_subjects/drug_use_and_dependence/amphetamines.html |dead-url = no }}</ref><ref name="Albertson_2011">{{cite book|veditors=Olson KR, Anderson IB, Benowitz NL, Blanc PD, Kearney TE, Kim-Katz SY, Wu AH | title = Poisoning & Drug Overdose | author = Albertson TE| year = 2011 | publisher = McGraw-Hill Medical | location = New York | isbn = 978-0-07-166833-0 | chapter = Amphetamines | pages = 77–79 | edition = 6th }}</ref><ref>{{cite web | title = Amphetamine Poisoning | url = http://emergency.unboundmedicine.com/emergency/ub/view/5-Minute_Emergency_Consult/307063/all/Amphetamine_Poisoning | work = Emergency Central | publisher = Unbound Medicine | date = 11 February 2011 | accessdate = 11 June 2013 | vauthors = Oskie SM, Rhee JW | archive-date = 2013-09-26 | archive-url = https://web.archive.org/web/20130926150016/http://emergency.unboundmedicine.com/emergency/ub/view/5-Minute_Emergency_Consult/307063/all/Amphetamine_Poisoning | dead-url = no }}</ref><ref name="pmid17874986">{{cite journal | vauthors = Isbister GK, Buckley NA, Whyte IM | title = Serotonin toxicity: a practical approach to diagnosis and treatment | journal = Med. J. Aust. | volume = 187 | issue = 6 | pages = 361–365 | date = September 2007 | pmid = 17874986 | doi =  | url = https://www.mja.com.au/system/files/issues/187_06_170907/isb10375_fm.pdf | access-date = 2018-05-27 | archive-date = 2014-07-04 | archive-url = https://web.archive.org/web/20140704062057/https://www.mja.com.au/system/files/issues/187_06_170907/isb10375_fm.pdf | dead-url = no }}</ref>| group = "sources" }}。甲基苯丙胺過量會因為{{link-en|多巴胺激活|dopaminergic}}及{{link-en|血清素激活|serotonergic}}的神經毒性而造成輕微的[[腦損傷|腦損傷]]<ref name="Malenka">{{cite book |vauthors = Malenka RC, Nestler EJ, Hyman SE |veditors = Sydor A, Brown RY |title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience |year = 2009 |publisher = McGraw-Hill Medical |location = New York |isbn = 978-0-07-148127-4 |page = 370 |edition = 2nd |chapter = 15 |quote = Unlike cocaine and amphetamine, methamphetamine is directly toxic to midbrain dopamine neurons. }}</ref><ref name="pmid19328213">{{cite journal |vauthors = Krasnova IN, Cadet JL |title = Methamphetamine toxicity and messengers of death |journal = Brain Res. Rev. |volume = 60 |issue = 2 |pages = 379–407 |date = May 2009 |pmid = 19328213 |pmc = 2731235 |doi = 10.1016/j.brainresrev.2009.03.002 |quote = Neuroimaging studies have revealed that METH can indeed cause neurodegenerative changes in the brains of human addicts (Aron and Paulus, 2007; Chang et al., 2007). These abnormalities include persistent decreases in the levels of dopamine transporters (DAT) in the orbitofrontal cortex, dorsolateral prefrontal cortex, and the caudate-putamen (McCann et al., 1998, 2008; Sekine et al., 2003; Volkow et al., 2001a, 2001c). The density of serotonin transporters (5-HTT) is also decreased in the midbrain, caudate, putamen, hypothalamus, thalamus, the orbitofrontal, temporal, and cingulate cortices of METH-dependent individuals (Sekine et al., 2006) ...<br />Neuropsychological studies have detected deficits in attention, working memory, and decision-making in chronic METH addicts ...<br /> There is compelling evidence that the negative neuropsychiatric consequences of METH abuse are due, at least in part, to drug-induced neuropathological changes in the brains of these METH-exposed individuals ...<br /> Structural magnetic resonance imaging (MRI) studies in METH addicts have revealed substantial morphological changes in their brains. These include loss of gray matter in the cingulate, limbic and paralimbic cortices, significant shrinkage of hippocampi, and hypertrophy of white matter (Thompson et al., 2004). In addition, the brains of METH abusers show evidence of hyperintensities in white matter (Bae et al., 2006; Ernst et al., 2000), decreases in the neuronal marker, N-acetylaspartate (Ernst et al., 2000; Sung et al., 2007), reductions in a marker of metabolic integrity, creatine (Sekine et al., 2002) and increases in a marker of glial activation, myoinositol (Chang et al., 2002; Ernst et al., 2000; Sung et al., 2007; Yen et al., 1994). Elevated choline levels, which are indicative of increased cellular membrane synthesis and turnover are also evident in the frontal gray matter of METH abusers (Ernst et al., 2000; Salo et al., 2007; Taylor et al., 2007). }}</ref>。甲基苯丙胺中毒死亡一般會出現在[[驚厥|驚厥]]及[[昏迷|昏迷]]之後<ref name="Desoxyn" />。

=== 精神病症 ===
濫用甲基苯丙胺會造成{{le|興奮劑精神病症|Stimulant psychosis}}，有許多不同的症狀（例如[[偏執狂|偏執狂]]、[[幻觉|幻觉]]、[[譫妄|譫妄]]及[[妄想|妄想]]等）<ref name="Schep" /><ref name="Cochrane" />。[[考科藍|考科藍]]研究有針對因濫用苯丙胺，右旋苯丙胺和甲基苯丙胺等興奮劑造成精神病症治療，進行的回顧研究，指出其中約有5%至15%的濫用者無法完全復原<ref name="Cochrane">{{cite journal |veditors = Shoptaw SJ, Ali R |vauthors = Shoptaw SJ, Kao U, Ling W |title = Treatment for amphetamine psychosis |journal = Cochrane Database Syst. Rev. |volume =  |issue = 1 |pages = CD003026 |year = 2009 |pmid = 19160215 |doi = 10.1002/14651858.CD003026.pub3 |quote = A minority of individuals who use amphetamines develop full-blown psychosis requiring care at emergency departments or psychiatric hospitals. In such cases, symptoms of amphetamine psychosis commonly include paranoid and persecutory delusions as well as auditory and visual hallucinations in the presence of extreme agitation. More common (about 18%) is for frequent amphetamine users to report psychotic symptoms that are sub-clinical and that do not require high-intensity intervention ...<br />About 5–15% of the users who develop an amphetamine psychosis fail to recover completely (Hofmann 1983) ...<br />Findings from one trial indicate use of antipsychotic medications effectively resolves symptoms of acute amphetamine psychosis. }}</ref><ref name="Hofmann">{{cite book |author = Hofmann FG |title = A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects |publisher = Oxford University Press |isbn = 978-0-19-503057-0 |location = New York |year = 1983 |page = 329 |edition = 2nd }}</ref>。同一份回顧研究也指出，根據至少一次的試驗，[[抗精神病药|抗精神病药]]可以有效改善急性甲基苯丙胺精神疾病的症狀<ref name="Cochrane" />。<!--{{link-en||Stimulant psychosis|Amphetamine psychosis}} may also develop occasionally as a treatment-emergent side effect.<ref name="Berman-2009">{{cite journal |vauthors = Berman SM, Kuczenski R, McCracken JT, London ED |title = Potential adverse effects of amphetamine treatment on brain and behavior: a review |journal = Mol. Psychiatry |volume = 14 |issue = 2 |pages = 123–142 |date = February 2009 |pmid = 18698321 |pmc = 2670101 |doi = 10.1038/mp.2008.90 }}</ref>-->

=== 緊急治療 ===
急性甲基苯丙胺中毒的治療主要是在治療其症狀，治療過程一開始可能會包括[[活性炭|活性炭]]及{{link-en|鎮靜劑|sedation}}<ref name="Schep" />，有關[[血液透析|血液透析]]或[[腹膜透析|腹膜透析]]應用在甲基苯丙胺解毒上的效果，目前還沒有足夠證據來確認其是否有效<ref name="Desoxyn" />{{link-en|強制性利尿|Forced acid diuresis}}（例如透過[[维生素C|维生素C]]）會增加甲基苯丙胺的排泄量，不過會增加重度酸中毒、引發癲癇或橫紋肌溶解的風險，因此不建議使用<ref name="Schep" />。高血壓會有{{link-en|顱內出血|intracranial hemorrhag}}的風險，若是嚴重的話，可以用注射{{link-en|苄胺唑啉|phentolamine}}或[[硝普钠|硝普钠]]來治療<ref name="Schep" />，若提供足量[[苯二氮䓬类|苯二氮䓬类]]鎮靜劑以及提供安靜的環境，血壓會漸漸下降<ref name="Schep" />。

在治療甲基苯丙胺過量造成的躁動和精神病時，可以用[[氟哌啶醇|氟哌啶醇]]等抗精神病藥<ref name="Richards 2015 review" /><ref>{{cite journal |vauthors = Richards JR, Derlet RW, Duncan DR |title = Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone |journal = Eur. J. Emerg. Med. |date = September 1997 |volume = 4 |issue = 3 |pages = 130–135 |pmid = 9426992 |doi = 10.1097/00063110-199709000-00003 }}</ref>。具有親脂性及中樞神經系統滲透性的[[Β受体阻断药|β阻断药]]（例如[[美托洛尔|美托洛尔]]及[[拉贝洛尔|拉贝洛尔]]）可以治療中樞神經系統及心血管的毒性<ref name="Medscape meth toxicity">{{cite encyclopedia |url = http://emedicine.medscape.com/article/820918-overview#showall |title = Methamphetamine Toxicity |section-url = http://emedicine.medscape.com/article/820918-treatment#showall |section = Treatment & Management |vauthors = Richards JR, Derlet RW, Albertson TE |website = Medscape |publisher = WebMD |access-date = 20 April 2016 |archive-date = 2016-04-09 |archive-url = https://web.archive.org/web/20160409114830/http://emedicine.medscape.com/article/820918-overview#showall |dead-url = no }}</ref>。混合的{{link-en|α阻断药|alpha blocker|α-}}及[[Β受体阻断药|β-阻断药]]拉貝洛爾在治療甲基苯丙胺引起的心動過速和高血壓上格外有效<ref name="Richards 2015 review">{{cite journal |vauthors = Richards JR, Albertson TE, Derlet RW, Lange RA, Olson KR, Horowitz BZ |title = Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review |journal = Drug Alcohol Depend. |date = May 2015 |volume = 150 |pages = 1–13 |doi = 10.1016/j.drugalcdep.2015.01.040 |pmid = 25724076 }}</ref>，在使用β阻断药來治療甲基苯丙胺中毒的過程，目前還沒有unopposed alpha stimulation的紀錄<ref name="Richards 2015 review" />。

=== 成瘾的治療與管理 ===
<!--{{Further|Addiction#Research}}-->
[[认知行为疗法|认知行为疗法]]是目前最有效治療精神興奮劑成瘾的療法<ref name="Nestler CBT">{{cite book |vauthors = Malenka RC, Nestler EJ, Hyman SE |veditors = Sydor A, Brown RY |title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience |year = 2009 |publisher = McGraw-Hill Medical |location = New York, USA |isbn = 978-0-07-148127-4 |page = 386 |edition = 2nd |chapter = Chapter 15: Reinforcement and Addictive Disorders |quote = Currently, cognitive–behavioral therapies are the most successful treatment available for preventing the relapse of psychostimulant use. }}</ref>。{{As of|2014}}，還沒有有效治療甲基苯丙胺成瘾的[[藥物治療|藥物療法]]<ref name="pmid24716825">{{cite journal |vauthors = Stoops WW, Rush CR |title = Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research |journal = Expert Rev Clin Pharmacol |volume = 7 |issue = 3 |pages = 363–374 |date = May 2014 |pmid = 24716825 |doi = 10.1586/17512433.2014.909283 |quote = Despite concerted efforts to identify a pharmacotherapy for managing stimulant use disorders, no widely effective medications have been approved. |pmc = 4017926 }}</ref><ref name="Cochrane 2013 treatments">{{cite journal |vauthors = Perez-Mana C, Castells X, Torrens M, Capella D, Farre M |title = Efficacy of psychostimulant drugs for amphetamine abuse or dependence |journal = Cochrane Database Syst. Rev. |volume = 9 |issue =  |pages = CD009695 |date = September 2013 |pmid = 23996457 |doi = 10.1002/14651858.CD009695.pub2 |quote = To date, no pharmacological treatment has been approved for [addiction], and psychotherapy remains the mainstay of treatment. ... Results of this review do not support the use of psychostimulant medications at the tested doses as a replacement therapy }}</ref><ref name="pmid23039267">{{cite journal |vauthors = Forray A, Sofuoglu M |title = Future pharmacological treatments for substance use disorders |journal = Br. J. Clin. Pharmacol. |volume = 77 |issue = 2 |pages = 382–400 |date = February 2014 |pmid = 23039267 |pmc = 4014020 |doi = 10.1111/j.1365-2125.2012.04474.x }}</ref>。甲基苯丙胺成瘾主要會透過[[多巴胺受體|多巴胺受體]]的增強活化及伏核中共定位[[N-甲基-D-天門冬胺酸受體|N-甲基-D-天門冬胺酸受體]]（NMDA受體）來調整{{#tag:ref|NMDA受體是電壓相依型[[配体门控离子通道|配体门控离子通道]]，需要同时结合谷氨酸和共激动剂（[[絲氨酸|{{smallcaps all]]或[[甘氨酸|甘氨酸]]）來打開離子通道<ref name="NHM-NMDA">{{cite book |vauthors = Malenka RC, Nestler EJ, Hyman SE |veditors = Sydor A, Brown RY |title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience |year = 2009 |publisher = McGraw-Hill Medical |location = New York, USA |isbn = 978-0-07-148127-4 |pages = 124–125 |edition = 2nd |chapter = Chapter 5: Excitatory and Inhibitory Amino Acids |quote = At membrane potentials more negative than approximately −50 mV, the Mg2+ in the extracellular fluid of the brain virtually abolishes ion flux through NMDA receptor channels, even in the presence of glutamate. ... The NMDA receptor is unique among all neurotransmitter receptors in that its activation requires the simultaneous binding of two different agonists. In addition to the binding of glutamate at the conventional agonist-binding site, the binding of glycine appears to be required for receptor activation. Because neither of these agonists alone can open this ion channel, glutamate and glycine are referred to as coagonists of the NMDA receptor. The physiologic significance of the glycine binding site is unclear because the normal extracellular concentration of glycine is believed to be saturating. However, recent evidence suggests that D-serine may be the endogenous agonist for this site. }}</ref>|group="note"}}<ref name="Amphetamine KEGG ΔFosB">{{cite web | title=Amphetamine – Homo sapiens (human) | url=http://www.genome.jp/kegg-bin/show_pathway?hsa05031+2354 | work=KEGG Pathway | accessdate=31 October 2014 | author=Kanehisa Laboratories | date=10 October 2014 | quote=Most addictive drugs increase extracellular concentrations of dopamine (DA) in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), projection areas of mesocorticolimbic DA neurons and key components of the "brain reward circuit". Amphetamine achieves this elevation in extracellular levels of DA by promoting efflux from synaptic terminals. ... Chronic exposure to amphetamine induces a unique transcription factor delta FosB, which plays an essential role in long-term adaptive changes in the brain. | archive-date=2018-07-23 | archive-url=https://web.archive.org/web/20180723034121/https://www.genome.jp/kegg-bin/show_pathway?hsa05031+2354 | dead-url=no }}</ref><ref name="Meth cAMP/calcium-dependent cascade">{{cite journal | vauthors = Cadet JL, Brannock C, Jayanthi S, Krasnova IN | title = Transcriptional and epigenetic substrates of methamphetamine addiction and withdrawal: evidence from a long-access self-administration model in the rat | journal = Mol. Neurobiol. | volume = 51 | issue = 2 | pages = 696–717 | year = 2015 | pmid = 24939695 | pmc = 4359351 | doi = 10.1007/s12035-014-8776-8 | quote = [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359351/figure/Fig1/ Figure 1]}}</ref>。[[镁|镁]]離子可以阻断受体[[钙通道|钙通道]]，因此可以抑制NMDA受体<ref name="NHM-NMDA" /><ref name="Magnesium">{{cite journal |author = Nechifor M |title = Magnesium in drug dependences |journal = Magnes. Res. |volume = 21 |issue = 1 |pages = 5–15 |date = March 2008 |pmid = 18557129 |doi =  |url = }}</ref>。

===依賴及戒斷症狀===
若固定的使用甲基苯丙胺，會出現[[藥物耐受性|藥物耐受性]]，若是因為非醫療的原因而使用，其耐受性會快速增強<ref>{{cite web |last = O'Connor |first = Patrick |title = Amphetamines: Drug Use and Abuse |url = http://www.merckmanuals.com/home/special_subjects/drug_use_and_abuse/amphetamines.html |work = Merck Manual Home Health Handbook |publisher = Merck |accessdate = 26 September 2013 |archive-date = 2007-02-17 |archive-url = https://web.archive.org/web/20070217053619/http://www.merck.com/mmhe/sec07/ch108/ch108g.html |dead-url = no }}</ref><ref name="Cochrane Abuse">{{cite journal |author = Pérez-Mañá C, Castells X, Torrens M, Capellà D, Farre M |title = Efficacy of psychostimulant drugs for amphetamine abuse or dependence |journal = Cochrane Database Syst. Rev. |volume = 9 |pages = CD009695 |year = 2013 |pmid = 23996457 |doi = 10.1002/14651858.CD009695.pub2 |editor1-last = Pérez-Mañá |editor1-first = Clara }}</ref>。若是有依賴性的使用者，其戒斷症狀和藥物耐受性的程度呈正相關<ref name="Cochrane Withdrawal" />。甲基苯丙胺戒斷產生的[[抑郁_(情绪)|抑郁]]會持續的比[[可卡因|可卡因]]戒斷症狀要長，其情形也較可卡因戒斷症狀要嚴重<ref name="pmid17990840"/>。

依目前考科藍文獻回顧有關甲基苯丙胺非醫療使用者的[[物質依賴|物質依賴]]及[[藥物戒斷|藥物戒斷]]資料來看，「若慢性重度使用者突然停用[甲基苯丙胺]，許多人會有時間限制的戒斷症狀，會在最後一次用藥後24小時內出現。」<ref name="Cochrane Withdrawal">{{cite journal |vauthors = Shoptaw SJ, Kao U, Heinzerling K, Ling W |title = Treatment for amphetamine withdrawal |journal = Cochrane Database Syst. Rev. |volume =  |issue = 2 |pages = CD003021 |year = 2009 |pmid = 19370579 |doi = 10.1002/14651858.CD003021.pub2 |editor = Shoptaw SJ |quote = The prevalence of this withdrawal syndrome is extremely common (Cantwell 1998; Gossop 1982) with 87.6% of 647 individuals with amphetamine dependence reporting six or more signs of amphetamine withdrawal listed in the DSM when the drug is not available (Schuckit 1999) ... Withdrawal symptoms typically present within 24 hours of the last use of amphetamine, with a withdrawal syndrome involving two general phases that can last 3 weeks or more. The first phase of this syndrome is the initial "crash" that resolves within about a week (Gossop 1982;McGregor 2005) }}</ref>。慢性重度使用者的戒斷症狀相當常見，慢性重度使用者中有87.6%會有戒斷症狀，會持續三週到四週，第一週會有明顯的「崩潰期」<ref name="Cochrane Withdrawal" />。甲基苯丙胺的戒斷症狀包括焦慮、{{link-en|藥物渴望|Craving (withdrawal)}}、[[煩躁|煩躁]]、[[疲勞|疲勞]]、[[多食症|胃口變好]]、{{link-en|運動增加|Psychomotor agitation}}或{{link-en|運動減少|psychomotor retardation}}、[[失乐|失去動力]]、[[失眠|失眠]]或是[[嗜睡症|嗜睡症]]以及[[清醒夢|清醒夢]]<ref name="Cochrane Withdrawal" />。

若孕婦使用甲基苯丙胺，其體內[[循環系統|循環系統]]會有甲基苯丙胺，而且會透過[[胎盤|胎盤]]傳遞給[[胎兒|胎兒]]，嬰兒也會在[[母乳|母乳]]中攝取到甲基苯丙胺<ref name="pregnancy" />。甲基苯丙胺濫用的婦女所生的嬰兒，考慮{{le|妊娠年齡|gestational}}調整後的頭圍數據顯著較小，而且其出生重量也會較輕<ref name="pregnancy" />。新生兒暴露在甲基苯丙胺下，也和其{{le|新生兒戒斷|neonatal withdrawal}}症候群有關，其症狀有激動，嘔吐和呼吸加快<ref name="pregnancy">{{cite journal |vauthors=Chomchai C, Na Manorom N, Watanarungsan P, Yossuck P, Chomchai S |title=Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand |journal=The Southeast Asian Journal of Tropical Medicine and Public Health |volume=35 |issue=1 |pages=228–31 |year=2004 |pmid=15272773 }}</ref>。不過此戒斷症狀相對較輕微，只有4%需要藥物干預<ref name="pmid17990840">{{cite journal|vauthors=Winslow BT, Voorhees KI, Pehl KA |title=Methamphetamine abuse|journal=American Family Physician |volume=76 |issue=8 |pages=1169–1174 |year=2007 |pmid=17990840 |doi=}}</ref>。

== 化學 ==
甲基苯丙胺爲人工合成，結構與[[苯丙胺|苯丙胺]]和[[MDMA|MDMA]]（摇头丸）近似，比起其他毒品，結構較簡單，[[分子量|分子量]]較小。

=== 合成过程 ===
甲基苯丙胺与[[甲卡西酮|甲卡西酮]]（methsy）、[[苯丙胺|苯丙胺]]、以及其它[[兴奋剂|兴奋剂]]的结构相似，可以用化学还原方法从[[麻黄碱|麻黄碱]]或[[伪麻黄碱|伪麻黄碱]]制得。大多数制备的原料属于日用品或可以从商店直接买到。因此合成甲基苯丙胺显得简单易行。在网络上可以找到许多转化合成方法，通常不大可信。最有经验的行家或求教于[[化学|化学]]课，或从那些生产安非他命的人员那儿学来。几乎每一种方法都要用到高度危险的化学品和流程。大多数的生产方法涉及到将麻黄碱/伪麻黄碱分子中[[羟基|羟基]]的[[氢化|氢化]]。在美国最通常的方式用到红[[磷|磷]]和[[碘|碘]]，形成[[氢碘酸|氢碘酸]]。另一个日渐普遍的方法是使用[[Birch还原法|Birch还原法]]<ref>{{cite web |url=http://www.illinoisattorneygeneral.gov/methnet/understandingmeth/basics.html |title=Illinois Attorney General |3=Basic Understanding Of Meth |publisher=Illinoisattorneygeneral.gov |date= |accessdate=2011-01-09 |archive-url=https://web.archive.org/web/20100910041147/http://www.illinoisattorneygeneral.gov/methnet/understandingmeth/basics.html |archive-date=2010-09-10 |dead-url=yes }}</ref>，用一次性锂电池中的金属锂替代金属钠（金属钠较难获得）。Birch还原法是极其危险的，因为碱金属和无水液氨都有极高的反应性。而且当加入反应物时，液氨的温度使其极易爆沸。另一种方法是[[苯基丙酮|苯基丙酮]]与[[甲胺|甲胺]]的[[还原胺化反应|还原胺化反应]]（Borch还原）<ref>{{cite web |url=http://www.erowid.org/archive/rhodium/chemistry/amph.alhg.html |title=A Synthesis of Amphetamine. J. Chem. Educ. 51, 671 (1974) |publisher=Erowid.org |date= |accessdate=2011-01-09 |archive-date=2010-10-17 |archive-url=https://web.archive.org/web/20101017135723/http://www.erowid.org/archive/rhodium/chemistry/amph.alhg.html |dead-url=no }}</ref>，所用的都是[[美国缉毒局|美国缉毒局]]的I级化学品。其他较不常见的方法使用其他的氢化法，比如用氢气和催化剂。

== 历史及各国管制政策 ==
{{medref}}
[[甲基苯丙胺|甲基苯丙胺]]與[[苯丙胺|苯丙胺]]的化學結構非常相似。甲基苯丙胺是由[[日本|日本]]化學家{{le|長井長義|Nagai Nagayoshi}}於1893年自[[麻黃鹼|麻黃鹼]]成功合成。1919年由{{link-ja|緒方章|緒方章}}完成了結晶化。

冰毒的正式學名是[[甲基安非他命|甲基安非他命]]，是一種強力興奮劑，能刺激中樞神經活動，化學結構與人體的[[腎上腺素|腎上腺素]]類似。由於外貌上為無色的粒狀透明晶體，故俗稱為「冰」。冰毒在發明之初，乃是戰爭時期用作減低士兵勞累，非自然地提升作戰能力的手段以增加其作戰效率，苯丙胺還被提供給必須超長時間工作的軍需廠工人使用，因而成癮者不計其數。戰後，掌握制造方法者開始自行生產並非法販售予平民，冰毒開始被濫用，作為派對藥物，其成癮問題和害處才開始漸漸浮現。由於成癮者向醫療機構求助的數字越來越大，令政府開始關注濫用問題，並研究對社會造成的危害。

甲基苯丙胺在[[第二次世界大戰|第二次世界大戰]]分別由[[同盟國_(第二次世界大戰)|同盟國]]與[[軸心國|軸心國]]以Pervitin<ref name=Pervitin>{{Cite web |url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=271075 |title=SID 271075 PubChem Substance Page on Methamphetamine |accessdate=2006-05-03 |archive-date=2014-03-18 |archive-url=https://web.archive.org/web/20140318151031/http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=271075 |dead-url=no }}</ref>之註冊名稱分發予前線，[[納粹德國|納粹]]軍廣發甲基苯丙胺予士兵以作[[興奮劑|興奮劑]]之用，特別是在[[蘇德戰爭|蘇德戰爭]]時的[[黨衛隊|黨衛隊]]人員及[[德意志國防軍|德意志國防軍]]。[[希特勒|希特勒]]亦曾注射甲基苯丙胺。[[日本|日本]]曾给士兵服用冰毒以提高戰鬥力。1941年武田製藥與大日本製藥（日本住友製藥）曾出產市販品，以及提供必須超長時間工作的軍需工廠工人使用，故在日本本土、臺灣、及日佔區都遺留下許多成癮患者。

1950年代，美国政府颁布法令将甲基苯丙胺规定为处方药，根据1951年出版的Arthur Grollman所著的《病理与药理学》一書，它可用于治疗嗜睡、后脑炎、帕金森综合症、酒精中毒，以及肥胖症。

1960年代，製造甲基苯丙胺的地下工廠開始普遍；1962年，冰毒首次作为一种违法毒品，被旧金山的摩托车黑帮制造出来，并在美国太平洋沿岸四处分发。这个黑帮很快便有了大批仿效者：制作冰毒所需要的原料非常普通，并且容易得到，比如外用酒精、碱液、麻黄碱和伪麻黄碱；最后一种当时作为非处方药供应。于是，作坊式实验室曾经生产了大量的违法甲基苯丙胺；墨西哥黑帮把大量廉价品带进了墨西哥。可以放进导管中抽吸的结晶甲基苯丙胺块在1980年代的夏威夷出现，并很快蔓延到美国大陆地区，成为最受欢迎的毒品种类。及至1980年，非醫療使用激增。其中，加州的[[聖地牙哥_(加利福尼亞州)|聖地牙哥]]市更被稱爲北美的冰毒聖地（英國《經濟學人》，1989年12月2日號）。

美國到1983年才制定法律管制持有甲基苯丙胺的前驅體和製造設備。1986年，美國制定了一份聯邦管制藥物取締法，名爲Federal Controlled Substance Analogue Enforcement Act，以打擊“設計毒品”（designer drugs）泛濫。儘管如此，吸食甲基苯丙胺仍在美國郊區（尤其是中西部和南部）上升，直至今日。而各州都在加緊立法打擊。

2008年《中华人民共和国禁毒法》颁布，在法律上正式将甲基苯丙胺纳入毒品管控。2018年甲基苯丙胺成为中国“头号毒品”<ref>{{cite news|publisher=中华人民共和国公安部|date=2019-06-18|url=http://www.gov.cn/xinwen/2019-06/18/content_5401230.htm|title=《2018年中国毒品形势报告》发布|accessdate=2019-06-26|archive-date=2019-06-26|archive-url=https://web.archive.org/web/20190626032131/http://www.gov.cn/xinwen/2019-06/18/content_5401230.htm|dead-url=no}}</ref>。

== 参见 ==
{{div col|cols=2}}
*[[1954年國際足協世界盃決賽|1954年國際足協世界盃決賽]]
* [[毒品|毒品]]
* [[苯丙胺|苯丙胺]]
* 甲基苯丙胺（desoxyephedrine）
* [[右旋甲基苯丙胺|右旋甲基苯丙胺]]
* [[麻黃鹼|麻黃鹼]]
* [[甲卡西酮|甲卡西酮]]
* [[苯乙胺|苯乙胺]]
* [[偽麻黃素|偽麻黃素]]（pseudoephedrine）
* [[药物管制|药物管制]]
* [[搖頭丸|搖頭丸]]
{{div col end}}

==備註==
{{noteFoot}}

<!--Notes list-->
{{reflist|group=note}}

== 來源群組 ==
<references group="sources" />

== 参考文献 ==
=== 脚注 ===
{{Reflist|2}}

=== 书目 ===
{{refbegin}}
*''Methamphetamine Use: Clinical and Forensic Aspects'', by Errol Yudko, Harold V. Hall,and Sandra B. McPherson. CRC Press, Boca Ratan, Fl, 2003.
*[https://web.archive.org/web/20060408080910/http://www.pa-chouvy.org/yaabaa-methamphetamine-production-traffic-consumption.htm''YAA BAA. Production, Traffic and Consumption of Methamphetamine in Mainland Southeast Asia", by Pierre-Arnaud CHOUVY & Joël MEISSONNIER Singapore University Press, 232 p., 2004.]
*[http://www.usdoj.gov/dea/pubs/cngrtest/ct020604.htm Fighting Methamphetamine in the Heartland: How Can the Federal Government Assist State and Local Efforts?] {{Wayback|url=http://www.usdoj.gov/dea/pubs/cngrtest/ct020604.htm |date=20060615014212 }} Statement of Armand McClintock Assistant Special Agent in Charge Indianapolis District Office Drug Enforcement Administration Before the House Committee on Government Reform Subcommittee on Criminal Justice, Drug Policy and Human Resources, February 6, 2004
*''Phenethylamines I Have Known And Loved: A Chemical Love Story'', [[亚历山大·舒尔金|Alexander Shulgin]] and Ann Shulgin，（ISBN 978-0-9630096-0-9）.  a.k.a. {{tsl|en|PiHKAL||PiHKAL}}. synthesis. [http://fj.sina.com.cn/xm/news/sz/2012-05-26/091038464.html online] {{Wayback|url=http://fj.sina.com.cn/xm/news/sz/2012-05-26/091038464.html |date=20151118101232 }}
{{refend}}

== 外部連結 ==
* [https://web.archive.org/web/20171201211851/http://methconference.org/ Second National Conference on Methamphetamine ~ Science & Response: 2007] This year's conference will once again be driven by collaboration and diversity - it will introduce the latest in methamphetamine research and innovative programming to the widest audience possible.
* [http://www.nyhealth.gov/diseases/aids/harm_reduction/crystalmeth/docs/meth_literature_index.pdf A Key to Methamphetamine-Related Literature] {{Wayback|url=http://www.nyhealth.gov/diseases/aids/harm_reduction/crystalmeth/docs/meth_literature_index.pdf |date=20060509211307 }} This is a comprehensive thematic index of methamphetamine-related journal articles with links from citations to the corresponding PubMed abstracts.
* [http://www.lifeormeth.com/ Life or Meth - Content Geared Towards The Gay Community] {{Wayback|url=http://www.lifeormeth.com/ |date=20060425051242 }}
* [http://www.msnbc.msn.com/id/8770112/site/newsweek/ Newsweek - "America's Most Dangerous Drug"] {{Wayback|url=http://www.msnbc.msn.com/id/8770112/site/newsweek/ |date=20060427141620 }}, see also [https://web.archive.org/web/20050810075049/http://slate.msn.com/id/2123838/ Slate - "Meth Madness At Newsweek"]
* [http://fj.sina.com.cn/xm/news/sz/2012-05-26/091038464.html Erowid Methamphetamine Vault] {{Wayback|url=http://fj.sina.com.cn/xm/news/sz/2012-05-26/091038464.html |date=20151118101232 }}
*[http://www.pbs.org/wgbh/pages/frontline/meth/ Frontline:  The Meth Epidemic（Accessed 2/15/06）] {{Wayback|url=http://www.pbs.org/wgbh/pages/frontline/meth/ |date=20180526115604 }}
* [http://www.geopium.org Geopium: Geopolitics of Illicit Drugs in Asia] {{WebCite|url=https://www.webcitation.org/60r2dD5tQ?url=http://www.geopium.org/ |date=20110811090417 |dateformat=iso }}
* [http://www.valleymeth.com/ Special Report on Meth in California's Central Valley] {{Wayback|url=http://www.valleymeth.com/ |date=20051028003126 }}
* [http://www.newyorker.com/printables/fact/050523fa_fact "New Yorker" story on the impact of widespread methamphetamine abuse] {{Webarchive|url=https://archive.is/20130104050738/www.newyorker.com/printables/fact/050523fa_fact |date=2013-01-04 }}
* [http://news.bbc.co.uk/1/hi/uk/4604047.stm BBC story on high levels of use of methamphetamine amongst the male gay community] {{Wayback|url=http://news.bbc.co.uk/1/hi/uk/4604047.stm |date=20060307070637 }}
* [http://www.usdoj.gov/dea/ Drug Enforcement Administration] {{Wayback|url=http://www.usdoj.gov/dea/ |date=20091008110843 }}:
** [http://www.dea.gov/concern/meth_factsheet.html Brief on amphetamines] {{Wayback|url=http://www.dea.gov/concern/meth_factsheet.html |date=20060427145058 }}
* [http://www.apaic.org Asia & Pacific Amphetamine - Type Simulant Information Centre] {{Wayback|url=http://www.apaic.org/ |date=20200723104030 }} - a very extensive information source mangaged by the United Nations Office on Drugs and Crime.
* [https://web.archive.org/web/20060427182657/http://www.rotten.com/library/crime/drugs/methamphetamine/ Rotten Library: Methamphetamine]
* [http://methinmissouri.livejournal.com/ Meth In Missouri] {{Wayback|url=http://methinmissouri.livejournal.com/ |date=20130818222546 }} A research blog on meth culture (especially in Missouri) that seeks your input- stories, comments, questions
* [http://www.notevenonce.com/ Montana Meth Project] {{Wayback|url=http://www.notevenonce.com/ |date=20060428104803 }}
* [http://www.reason.com/sullum/090205.shtml Is Meth A Plague, A Wildfire, Or the Next Katrina? ~ Reason.com] {{Wayback|url=http://www.reason.com/sullum/090205.shtml |date=20060423170603 }}
* [https://web.archive.org/web/20170924081521/http://crystalbreaks.org/ Crystal Breaks] A Chicago-area campaign addressing meth use in the gay community.
* [http://www.crystalmeth.org Crystal Meth Anonymous] {{Wayback|url=http://www.crystalmeth.org/ |date=20200813035458 }} A 12-Step-based Meth Recovery group.
* [http://2stopmeth.org/main.php?pg=gallery Meth Strike Force] {{Wayback|url=http://2stopmeth.org/main.php?pg=gallery |date=20060207050138 }} GALLERY and more

{{Aphrodisiacs}}
{{Euphoriants}}
{{ADHD_pharmacotherapies}}

{{Authority control}}
[[Category:降食欲剂|Category:降食欲剂]]
[[Category:强心剂|Category:强心剂]]
[[Category:多巴胺激动剂|Category:多巴胺激动剂]]
[[Category:安乐药|Category:安乐药]]
[[Category:日本发明|Category:日本发明]]
[[Category:甲基苯丙胺|]]
[[Category:单胺氧化酶抑制剂|Category:单胺氧化酶抑制剂]]
[[Category:血清素受体激动剂|Category:血清素受体激动剂]]
[[Category:精神药物|Category:精神药物]]
[[Category:毒品|Category:毒品]]
[[Category:1890年代发现的物质|Category:1890年代发现的物质]]